However, tumour xenografts were reduced by 50% by an optimized B subunit-p53 inhibitor complex after 6× 10 mg/kg administrations every 48 h [143], whereas a single 4μg/kg VT1 treatment eliminated a xenograft tumour within 7 days [102]. Here, TP53 is linked to neoplasm.